Rigel Pharmaceuticals Inc.
RIGL | NASDAQ
$47.09
+$0.45 (+0.96%)
At close: Sep 21, 2026, 4:00 PM ET
$47.09
$0 (0.00%)
After-hours:
Sep 21, 2026, 7:30 PM ET
Market Data
Market Cap $862.94M
Enterprise Value $815.88M
Beta 1.20
Average Volume 368.34K
Shares Outstanding (Diluted) 19.57M
Shares Change YoY 7.75%
Institutional Ownership 86.92%
Exchange NASDAQ
ISIN US7665597024
Price Performance
Price Change 1M 2.4%
Price Change 3M 32.2%
Price Change 6M 79.1%
Price Change YTD 12.6%
Price Change 1Y 36.7%
Price Change 3Y 332.0%
Price Change 5Y 25.9%
1M CAGR (ann.) 18.9%
1Y CAGR (ann.) 36.3%
5Y CAGR (ann.) 3.8%
All-Time CAGR -4.2%
Valuation
PE Ratio 2.89
Forward PE 8.81
PEG Ratio 0.01
Forward PEG 0.08
PS Ratio 3.15
Forward PS 2.30
PB Ratio 2.05
P/FCF Ratio 10.61
P/Adj. FCF Ratio 14.00
P/OCF Ratio 11.00
EV/Sales 2.95
EV/EBIT 8.93
EV/EBITDA 8.76
EV/FCF 9.94
Earnings Yield 34.7%
FCF Yield 9.4%
Adj. FCF Yield 7.1%
Financial Health
Net Cash $56.09M
Total Debt $39.95M
Cash & Short-Term Investments $95.33M
Total Assets $521.07M
Current Ratio 1.95
Quick Ratio 1.79
Debt / Equity Ratio 0.09
Debt / EBITDA 0.43
Debt / FCF 0.49
OCF / Debt 2.06
Interest Coverage 15.00
Altman Z-Score 4.06
Piotroski F-Score 4
Margins & Profitability
Gross Profit Margin 91.4%
Operating Profit Margin 31.4%
EBITDA Margin 34.0%
Net Profit Margin 116.3%
FCF Margin 29.7%
Adj. FCF Margin 22.5%
SBC / Revenue 5.9%
SBC Impact (per share) -24.2%
Returns
Return on Assets 61.8%
Return on Equity 96.5%
Return on Invested Capital 18.7%
Return on Capital Employed 20.4%
Return on Tangible Assets 75.4%
Historical Growth (CAGR)
Revenue CAGR 3Y 29.8%
Revenue CAGR 5Y 13.9%
Revenue CAGR 10Y 22.9%
EPS CAGR 3Y 123.0%
EPS CAGR 5Y 180.9%
EPS CAGR 10Y 358.6%
FCF CAGR 3Y 105.1%
FCF CAGR 5Y 1131.3%
FCF CAGR 10Y 69.7%
Analyst Forecasts
Analyst Rating Buy
Analyst Count 15
EPS Growth Next 3Y -33.5%
Revenue Growth Next 3Y 21.6%
Earnings Date Nov 2, 2026
EPS Estimate (next Q) $0.92
EPS Growth Est (next Q) -36.9%
Revenue Est (next Q) $80.1M
Revenue Growth Est (next Q) 15.3%
Fair Value Estimates
Graham Number $91.82
Graham Upside 95.0%
Lynch Fair Value $408
Lynch Upside 766.4%
Price Target $67
Price Target Upside 42.3%
Cash Flow
Operating Cash Flow $82.11M
Free Cash Flow $82.11M
Adj. Free Cash Flow $62.25M
FCF Per Share $4.28
OCF Per Share $4.28
OCF/S Ratio 28.7%
Income Statement
Revenue $276.79M
Gross Profit $252.95M
Operating Income $87.05M
EBITDA $93.18M
Net Income $321.91M
EPS (Diluted) $16.32
Revenue / Employee $1.6M
Profit / Employee $1.86M
Employees 173
Add to Watchlist
Select watchlists to add or remove RIGL